BRII-B (02137.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Aug21

BRII-B released FY2025 Q1 earnings on August 21 (BJT) with actual revenue of HKD 531.74 K and EPS of HKD -0.1095

15:00

BRII-B released FY2025 Semi-Annual Earnings on August 21 After-Market (BJT), actual revenue HKD 1.075 M (forecast HKD 0), actual EPS HKD -0.2215 (forecast HKD -0.2955)

11:00

BRII-B released FY2025 Q2 earnings on August 21 After-Market BJT, actual revenue HKD 15.49 M, actual EPS HKD -0.1094

11:00

Aug13

BRII-B to Release FY2025 Semi-Annual Earnings on August 21, 2025 (BJT), Forecast EPS HKD -0.2863

00:25

Jul17

Brii Bioscience Grants Huaren Healthcare Exclusive License to Develop and Commercialize New Drug in Greater China

02:43

May8

Brii Biosciences Announces Data from Chronic Hepatitis B Treatment Phase 2 Study

00:23

Schedules & Filings

Schedules

Filings

Aug21

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 543.43 K, Net Income -81.03 M, EPS -0.1119

Mar21

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 14.78 M, Net Income -121.08 M, EPS -0.1656

Aug19

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 11.9 M, Net Income -150.72 M, EPS -0.2065

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More